Warberg Asset Management »

Calidi Biotherapeutics shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Calidi Biotherapeutics shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $28k 19k 1.52

More positions owned by Warberg Asset Management

Spdr S&p 500 Etf Tr Put Put Option
Invesco Qqq Tr Put Put Option
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Sea Note 2.375%12/0 (Principal)
Western Digital Corp Note 3.000%11/1 (Principal)
Cnx Res Corp Note 2.250% 5/0 (Principal)
Axon Enterprise Note 0.500%12/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Box Note 1/1 (Principal)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Workiva Note 1.125% 8/1 (Principal)

View all positions for Warberg Asset Management

Top funds holding Calidi Biotherapeutics

HighTower Advisors
Vanguard Group
Geode Capital Management
Belpointe Asset Management
Warberg Asset Management
Rs Crum
UBS Group
Highbridge Capital Management
Finepoint Capital
Apollo Management Holdings
Royal Bank of Canada
Barrett & Company
Advisor Group Holdings
FMR
Tradewinds Capital Management

View all funds holding Calidi Biotherapeutics